Results
1 -
10 of
33
(Click
here to explore results)
- Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 9 From HTS to Market: the Discovery and Development of Maraviroc, a CCR5 Antagonist for the Treatment of HIV. Chris Barber, David Pryde
, 2011
, Pages 183-214
- Neglected Diseases and Drug Discovery, Chapter 12 Managing the HIV Epidemic in the Developing World – Progress and Challenges. Elna van der Ryst, Michael J Palmer, Cloete van Vuuren
, 2012
, Pages 322-365
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
- Drug Design Strategies: Quantitative Approaches, Chapter 1 The Evolution of Quantitative Drug Design. Keith James
, 2012
, Pages 1-34
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 13 Cobicistat and Ritonavir as Pharmacoenhancers for Antiviral Drugs. Lianhong Xu, Manoj C. Desai
, 2013
, Pages 451-481
- Amino Acids, Peptides and Proteins: Volume 41, Peptide-derived mid-sized anti-HIV agents. Nami Ohashi, Hirokazu Tamamura
, 2017
, Volume 41
, Pages 1-29
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Structural Virology, Chapter 15 Development of Anti-HIV Drugs. Roxana M. Coman, Robert McKenna
, 2011
, Pages 291-318
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 4 Primary, Secondary and Tertiary Amines and their Isosteres. D. K. Walker, R. M. Jones, A. N. R. Nedderman, P. A. Wright
, 2010
, Pages 168-209
- Synthetic Methods in Drug Discovery: Volume 2, Chapter 15 Fluorination Approaches. Duncan L. Browne, Paul Richardson
, 2016
, Volume 2
, Pages 263-370